Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 30, 2012 08:30 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Appoints Vice President Business Development

TORONTO, Jan. 30, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
January 05, 2012 16:30 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Webcast of Presentation at the Biotech Showcase 2012

TORONTO, Jan. 5, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
November 25, 2011 17:14 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Files Preliminary Base Shelf Prospectus and Shelf Registration Statement

TORONTO, Nov. 25, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development, and manufacture of novel...
November 23, 2011 12:30 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Webcast of Presentation at the 23rd Annual Piper Jaffray Healthcare Conference

TORONTO, Nov. 23, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
November 15, 2011 06:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics' Manufacturing Facility Passes FDA cGMP and Pre-Approval Inspection

TORONTO, Nov. 15, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development, and manufacture of novel...
October 31, 2011 08:30 ET | Source: Intellipharmaceutics International Inc.

FDA Accepts for Filing Intellipharmaceutics' ANDA for Generic Lamictal(R) XR(TM)

TORONTO, Oct. 31, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) today announced the U.S. Food and Drug Administration (FDA) has accepted for filing its...
October 07, 2011 16:30 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Third Quarter 2011 Results

TORONTO, Oct. 7, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
September 26, 2011 11:30 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Webcast of Presentation at the JMP Securities Healthcare Conference

TORONTO, Sept. 26, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
August 18, 2011 06:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics and Par Pharmaceutical Expand Development and Commercialization Agreement

TORONTO, Aug. 18, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
July 05, 2011 20:00 ET | Source: Intellipharmaceutics International Inc.

Intellipharmaceutics Announces Second Quarter 2011 Results

TORONTO, July 5, 2011 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...